Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04027777 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

StatusRecruiting
PhaseNot applicable
SponsorAktiia SA
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 185 to 355 Primary and study completion dates: Dec 31, 2024 to Dec 31, 2027 · Eligibility criteria expanded, about 774 words · Study arms: 3 to 7v12 Show 3 more changesShow less
    • Primary and study completion dates: Dec 31, 2024 to Dec 31, 2027
    • Eligibility criteria expanded, about 774 words
    • Study arms: 3 to 7

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024v11
  3. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2023v10
  4. Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022v9
  5. Re-verified, no change to tracked fieldsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Active, Not Recruiting to Recruiting Enrollment target: 105 to 185 · Primary and study completion dates: May 30, 2021 to Dec 31, 2021 · Eligibility criteria expanded, about 324 words · 2 morev7 Show 5 more changesShow less
    • Enrollment target: 105 to 185
    • Primary and study completion dates: May 30, 2021 to Dec 31, 2021
    • Eligibility criteria expanded, about 324 words
    • Site details revised
    • Study arms: 1 to 3

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Sep 30, 2020 to May 30, 2021 Trial status: Recruiting to Active, Not Recruiting · Site details revisedv6 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
  3. Primary and study completion dates: Jan 6, 2020 to Sep 30, 2020 Trial status: Completed to Recruiting · Enrollment target: 85 to 105 · Site details revisedv5 Show 3 more changesShow less
    • Trial status: Completed to Recruiting
    • Enrollment target: 85 to 105
    • Site details revised
  4. Trial status: Recruiting to Completed Primary and study completion dates changed from estimate of Jan 31, 2020 to Jan 6, 2020 · Site details revisedv4 Show 2 more changesShow less
    • Primary and study completion dates changed from estimate of Jan 31, 2020 to Jan 6, 2020
    • Site details revised
  5. Primary completion date: Oct 31, 2019 to Jan 31, 2020 Completion date: Nov 30, 2019 to Jan 31, 2020 · Eligibility criteria expanded, about 35 words · Study description expanded, about 25 wordsv3 Show 3 more changesShow less
    • Completion date: Nov 30, 2019 to Jan 31, 2020
    • Eligibility criteria expanded, about 35 words
    • Study description expanded, about 25 words

    See this version in full on ClinicalTrials.gov ↗

  6. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jul 29, 2019 to Aug 6, 2019v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 29, 2019 to Aug 6, 2019
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aktiia SA
9 trials monitored
See all monitored trials
Single-centre prospective observational study to validate the performance of the Aktiia SA optical blood pressure monitoring (OBPM) device at the wrist against blood pressure measurements obtained by double auscultation at the upper arm during four weeks
Trial Details
NCT Number NCT04027777
Lead Sponsor Aktiia SA
Collaborators: University of Lausanne Hospitals
Conditions Blood Pressure
Enrollment 355 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov